Bionomics Limited Announces Pricing of Initial Public Offering in the United States - read this article along with other careers information, tips and advice on BioSpace
ADELAIDE, Australia, Dec. 16, 2021 /PRNewswire/ — Bionomics Limited (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the pricing.
/PRNewswire/ Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the.
ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development program for the acute treatment of Social Anxiety Disorder (SAD) and other anxiety-related disorders. In November 2019, the FDA granted.